CDKN1B and cholangiocarcinoma: Furthermore, the Wnt target, MYC, inhibits the transcription of several other CKIs, including CDKN1A (p21), CDKN1B (p27), and CDKN2B (p15) [151], all of which demonstrate hypermethylation Ov-CCA and CCA.